000 01493 a2200409 4500
005 20250511181219.0
264 0 _c19920804
008 199208s 0 0 eng d
022 _a0002-9513
024 7 _a10.1152/ajprenal.1992.262.6.F1055
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Y X
245 0 0 _aDopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
_h[electronic resource]
260 _bThe American journal of physiology
_cJun 1992
300 _aF1055-60 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
_xanalogs & derivatives
650 0 4 _aAnimals
650 0 4 _aBenzazepines
_xpharmacology
650 0 4 _aDopamine Agents
_xpharmacology
650 0 4 _aFenoldopam
650 0 4 _aGlomerular Filtration Rate
_xdrug effects
650 0 4 _aGlycine
_xpharmacology
650 0 4 _aMale
650 0 4 _aNatriuresis
_xdrug effects
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aReceptors, Dopamine
_xmetabolism
650 0 4 _aReceptors, Dopamine D1
650 0 4 _aRenal Circulation
_xdrug effects
650 0 4 _aTime Factors
650 0 4 _aVascular Resistance
_xdrug effects
700 1 _aGellai, M
700 1 _aBrooks, D P
773 0 _tThe American journal of physiology
_gvol. 262
_gno. 6 Pt 2
_gp. F1055-60
856 4 0 _uhttps://doi.org/10.1152/ajprenal.1992.262.6.F1055
_zAvailable from publisher's website
999 _c1358928
_d1358928